Exchange: NASDAQ·Updated 12:00 AM EST

GBIO Generation Bio Co

$5.36
$0.00
(0.00%)
Pre-Market
Prev Close $5.36
Reported EarningsNov 5
Mkt Cap$35.98M

About GBIO

Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
41

Bearish Sentiment

How do you feel about GBIO?

Advertisement|Remove ads.